Axsome Therapeutics, Inc. 10-K filing
Filed 2026-02-23 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001193125-26-064267
- Form type
- 10-K
- CIK
- 0001579428
- Primary document
- https://www.sec.gov/Archives/edgar/data/1579428/000119312526064267/axsm-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Axsome Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $638.5M | - | - |
| Operating Income | $-166.8M | - | - |
| Net Income | $-183.2M | - | - |
| Eps Basic | -3.68 | - | - |
| Eps Diluted | -3.68 | - | - |
| Cash And Equivalents | $322.9M | - | - |
| Total Assets | $689.8M | - | - |
| Total Liabilities | $601.5M | - | - |
| Shareholders Equity | $88.3M | - | - |
| Operating Cash Flow | $-93.4M | - | - |
| Capital Expenditures | $480,000 | - | - |